Pharma business news, market intelligence, and CEO-level case studies
Archive
IQVIA Signal: Wegovy Pill May Expand the GLP-1 Market, Not Just Replace Injections | Witfire Elite View Witfire Elite Pharma Markets Case Studies Strategy Long Read Pharma Market…
FDA’s Digital Liver Break: How AI Toxicology Could Change Drug Development Before Phase I | Witfire Elite View Witfire Elite FDA & Regulatory Case Studies Strategy Long Read…
The China Biotech Pipeline Grab: How Big Pharma Started Buying Innovation From China | Witfire Elite View Witfire Elite Pharma Markets Case Studies Strategy Long Read Pharma Market…
The Pharma Tariff War: How US Drug Pricing Pressure Is Forcing Big Pharma to Rewrite Global Strategy | Witfire Elite View Witfire Elite Pharma Markets Case Studies Strategy…
How GLP-1 Became Pharma’s Most Powerful Growth Story
GLP-1 Market: The obesity and diabetes drug race is becoming one of the biggest business stories in global pharma. Reuters reported that analysts now estimate global obesity drug…
The Middle East conflict is now moving directly into pharma boardroom risk. Oil-market stress has intensified, with Vitol’s Bahrain chief warning that the market may still be underpricing…
The pharmaceutical business is no longer a small product-driven market. It is becoming one of the most strategic global industries. IQVIA has projected that global medicine spending may…